2018-2019 Budget: Australian Government confirms support to companies undertaking clinical trials

Australia's biotech industry has applauded the Federal Government's 2018-19 Budget, which introduces a raft of changes to the R&D Tax Incentive program that support and reward higher-value and more intensive
R&D investment in Australia.

Read more about the changes here!

Budget 2018.JPG